Protection of Cells from Methotrexate Toxicity by 7-Hydroxymethotrexate
Author Information
Author(s): J.M. Gaukroger, L. Wilson
Primary Institution: University Department of Dermatology, Western Infirmary, Glasgow
Hypothesis
The study investigates the protective role of 7-hydroxymethotrexate against methotrexate toxicity in human melanoma and acute lymphoblastic leukaemia cells.
Conclusion
7-hydroxymethotrexate reduces the toxicity of methotrexate to melanoma cells by decreasing drug uptake and increasing efflux.
Supporting Evidence
- 7-hydroxymethotrexate is significantly less toxic to melanoma and ALL cells than methotrexate.
- 7-hydroxymethotrexate reduces the initial cellular uptake rate of methotrexate in melanoma cells.
- Extracellular methotrexate stimulates the exit of methotrexate from cells, while 7-hydroxymethotrexate has a lesser effect.
Takeaway
This study shows that a substance called 7-hydroxymethotrexate helps protect certain cancer cells from a harmful drug called methotrexate.
Methodology
Cell growth survival studies were conducted using human melanoma and acute lymphoblastic leukaemia cell lines, measuring the effects of methotrexate and its 7-OH metabolite on cell uptake and efflux.
Limitations
The study primarily focuses on in vitro conditions, which may not fully replicate in vivo responses.
Participant Demographics
The study involved human melanoma and acute lymphoblastic leukaemia cell lines.
Want to read the original?
Access the complete publication on the publisher's website